52 Understanding cetuximab response and immune modulation in colorectal cancer using patient-derived organotypic tumor spheroids
Main Authors: | Aaron Goldman, Ketki Bhise, Chunxiao (Emma) Cui, Kirti Khardenavis, Anthony Attardo, Danielle Hagee, Sinal Patel, Julia Vail, Amir Aref, Nicholas Barris, Alyssa Martin, Michael A Perricone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade
by: Portell, Andrew, et al.
Published: (2018) -
The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey
by: Sapna Krishnamurthy, et al.
Published: (2022-05-01) -
Cetuximab reconstitutes proinflammatory cytokine secretions and tumour-infiltrating capabilities of sMICA-inhibited NK cells in HNSCC tumour spheroids.
by: Stephan eKloess, et al.
Published: (2015-11-01) -
442 CAIX targeted CAR-T cells exhibited antitumor efficacy on renal cell carcinoma (RCC) patient derived organotypic tumor spheroids (PDOTS)
by: Sabina Signoretti, et al.
Published: (2023-11-01) -
Organotypic Modeling of the Tumor Landscape
by: Maria M. Haykal, et al.
Published: (2020-11-01)